Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study

Peer review reports

Original Submission
20 Oct 2016	Submitted	Original manuscript
2 Dec 2016	Reviewed	Reviewer Report - Tatjana Pekmezovic
28 Dec 2016	Reviewed	Reviewer Report - Adam Handel
10 Feb 2017	Author responded	Author comments - Meritxell Sabidó Espin
Resubmission - Version 2
10 Feb 2017	Submitted	Manuscript version 2
Publishing
6 Mar 2017	Editorially accepted
23 Mar 2017	Article published	10.1186/s12883-017-0831-4

Back to article page